Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22,529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic peripheral blood stem cell transplantation is a promising and safe choice for the treatment of refractory/relapsed acute myelogenous leukemia, even with a higher leukemia burden.
Zhang WP, Yang D, Song XM, Ni X, Chen J, Chen L, Yang JM, Zhou H, Cheng H, Liu BH, Li HM, Wang JM. Zhang WP, et al. Among authors: yang d, yang jm. Biol Blood Marrow Transplant. 2013 Apr;19(4):653-60. doi: 10.1016/j.bbmt.2013.01.015. Epub 2013 Jan 22. Biol Blood Marrow Transplant. 2013. PMID: 23353118 Free article.
Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II study.
Zhang WP, Wang ZW, Hu XX, Chen J, Yang D, Song XM, Gao L, Ni X, Chen L, Xia XX, Zhou H, Tang GS, Cheng H, Luo YR, Li HM, Yang JM, Wang JM. Zhang WP, et al. Among authors: yang d, yang jm. Bone Marrow Transplant. 2019 Jun;54(6):894-902. doi: 10.1038/s41409-018-0356-5. Epub 2018 Oct 19. Bone Marrow Transplant. 2019. PMID: 30337697 Clinical Trial.
22,529 results
You have reached the last available page of results. Please see the User Guide for more information.